Amlapitta as a Precursor of Metabolic Syndrome: An Integrative Review From Ayurvedic and Biomedical Perspectives

Background: Metabolic Syndrome (MetS) is a rapidly escalating global health crisis involving insulin resistance, central obesity, and dyslipidemia. While modern medicine focuses on managing established metabolic risks, emerging evidence suggests that functional digestive disturbances and low-grade inflammation precede these overt metabolic changes. Objective: This integrative review aims to conceptualize the Ayurvedic diagnosis of Amlapitta not merely as a gastric disorder, but as a prodromal (early warning) stage of Metabolic Syndrome. Discussion: In Ayurveda, Agni (digestive fire) is central to health, and Amlapitta arises from Agni impairment and Pitta aggravation. Classical texts describe a progression from Amlapitta to Medovaha Srotodushti (fat metabolism disorder) and Prameha (diabetes). This parallels biomedical findings where Gastroesophageal Reflux Disease (GERD) is strongly linked to visceral adiposity, cytokine-induced inflammation, and insulin resistance. Both systems indicate that metabolic dysregulation begins in the gut. Conclusion: Identifying Amlapitta as an early metabolic marker offers a novel window for prevention. Integrating Ayurvedic correction of Agni with modern lifestyle interventions at this stage could prevent the progression to full-blown Metabolic Syndrome.